サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439290

椎体間ケージ - 世界市場の考察、競合情勢、市場予測（2030年）

Interbody Cages - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
椎体間ケージ - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の椎体間ケージの市場規模は、2024年～2030年の予測期間にCAGRで4.72%の成長が見込まれます。椎体間ケージの需要は、主に椎間板変性症（DDD）、脊椎固定術、脊椎損傷などの脊椎疾患の増加によって後押しされています。さらに、先進の革新的な技術の採用の増加、低侵襲手術の需要の増加、事故の件数の増加、製品の発売と承認の増加などが、2024年～2030年の予測期間に椎体間ケージ市場全体の成長に寄与しています。

椎体間ケージの市場力学

椎体間ケージ市場は、さまざまな要因によって製品需要が積極的に伸びていますが、その主な要因の1つは、脊椎疾患や整形外科疾患にかかりやすい老年人口の増加です。

Ministry of Statistics and Programme Implementation（2021）によると、2021年のインドにおける老年人口は、男性6,700万人、女性7,100万人の合計1億3,800万人近くでした。

世界保健機関（WHO）（2022）によると、80歳以上の高齢者数は2020年～2050年に3倍に増え、4億2,600万人に達すると予測されています。2030年までに、世界の6人に1人が60歳以上となります。このとき、60歳以上の人口に占める割合は、2020年の10億人から2030年までに14億人に増加します。2050年までに、世界の60歳以上の人口は2倍になります。2050年までに、高齢者の80％が低中所得国に住むことになります。同資料によると、日本ではすでに人口の30％が60歳以上です。

脊椎の椎間板は、加齢とともに自然に退行性の変化を起こします。椎間板は水分を失い、柔軟性を失い、磨耗や損傷を経験します。こうした加齢に伴う変性変化は、椎間板ヘルニアや椎間板の崩壊につながる可能性があり、外科的介入が必要となり、脊椎固定術が必要となる場合があります。この固定は、脊柱の一部を支える椎体間ケージを使うことで行えます。このように、高齢者は脊椎疾患や整形外科疾患にかかりやすいため、椎体間ケージの需要は高齢化と並行して成長すると予測されます。

また、米国疾病予防管理センター（CDC）の2022年5月の発表によると、米国では毎年、65歳以上の高齢者の転倒事故が3,600万件発生しています。転倒の5件に1件は、骨折や頭部損傷などの重症を引き起こしています。

上記の要因に加え、製品の上市と承認、研究活動の活発化などの戦略的活動も、2024年～2030年の予測期間の椎体間ケージ市場の成長に寄与する見込みです。例えば2023年1月、FDAはEminent SpineのEminent Spine 3D Cervical Interbody Fusion Systemを承認しました。このシステムは、C2～C3椎間板からC7～T1椎間板までの1椎間板レベルの頸椎の椎間板変性症（DDD）の骨格成熟患者における椎体間固定術に適応されます。このように、製品の発売や承認が増加し、外科医、医療従事者、患者の間で椎体間ケージの利点に対する認識が高まっていることから、予測期間に椎体間ケージの需要が増加が見込まれます。

したがって、前述の要因が、2024年～2030年の予測期間に椎体間ケージの全体的な市場成長を促進します。

しかし、熟練度の低い専門家の利用可能性、椎体間ケージの誤装着や移動などのインプラント関連の合併症などが椎体間ケージ市場の需要を抑制する可能性があります。

椎体間ケージ市場のセグメント分析

椎体間ケージの製品タイプセグメントでは、腰椎固定デバイスカテゴリが2023年に大きな収益シェアを獲得する見込みです。

各製品タイプの椎体間ケージ市場における成長予測は、市場動向、手術技術の進歩、特定の脊椎疾患の流行などのさまざまな要因によって異なる可能性があります。

しかし、近年では、腰椎椎間板変性症（DDD）、脊椎すべり症、脊柱管狭窄症など、腰部に影響を及ぼすもっとも一般的な疾患である腰椎疾患の有病率が高いため、腰椎固定デバイスセグメントが総合的に大きな成長を示すと予測されています。これらの疾患は、腰椎固定術などの外科的介入を必要とすることが多いです。腰椎疾患の高い有病率が腰椎固定デバイスの需要を促進しています。

当レポートでは、世界の椎体間ケージ市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 椎体間ケージ市場レポートのイントロダクション

第2章 椎体間ケージ市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 椎体間ケージ市場の主な要因の分析

  • 椎体間ケージ市場の促進要因
    • 脊椎疾患の有病率の上昇
    • さまざまな治療アプローチを使用した痛みの軽減と生活の質の向上に対する患者の需要の増加
    • 脊椎疾患や整形外科疾患にかかりやすい老年人口の増加
  • 椎体間ケージ市場の抑制要因と課題
    • 椎体間ケージの位置ずれや移動などのインプラント関連の合併症
    • 数少ない熟練した専門家の利用可能性
  • 椎体間ケージ市場の機会
    • 生分解性椎体間ケージや3Dプリントケージなどの技術の進歩の増加
    • ロボット支援による椎体間ケージ留置術の採用

第5章 椎体間ケージ市場のポーターのファイブフォース分析

第6章 椎体間ケージ市場レイアウト

  • 製品タイプ別
    • 頸椎固定デバイス
    • 胸椎固定デバイス
    • 腰椎固定デバイス
  • 材料別
    • チタン
    • ポリエーテルエーテルケトン（PEEK）
    • その他
  • エンドユーザー別
    • 病院
    • 外来手術センター
  • 地域別
    • 北米の椎体間ケージの市場規模（2021年～2030年）
    • 欧州の椎体間ケージの市場規模（2021年～2030年）
    • アジア太平洋の椎体間ケージの市場規模（2021年～2030年）
    • その他の地域の椎体間ケージの市場規模（2021年～2030年）

第7章 椎体間ケージ市場の企業と製品のプロファイル

  • B. Braun SE
  • Ackermann Instrumente GmbH
  • Alphatec Spine Inc.
  • Eminent Spine
  • Medtronic plc
  • Zener Medtec
  • Rivarp Medical Private Limited
  • CarboFix Orthopedics Ltd
  • Intelivation LLC
  • Medacta International
  • Surgalign Spine Technologies
  • SeaSpine Orthopedics Corporation
  • Elite Surgical
  • Aurora Spine, Inc.
  • Zimmer Biomet
  • Globus Medical
  • Johnson & Johnson
  • Stryker
  • Ulrich Medical USA
  • Orthofix US LLC

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightについて

第11章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Interbody Cages Market in Global (2021-2030)
  • Table 3: Interbody Cages Market in Global by Product Type (2021-2030)
  • Table 4: Interbody Cages Market in Global by Material (2021-2030)
  • Table 5: Interbody Cages Market in Global by End-User (2021-2030)
  • Table 6: Interbody Cages Market in Global by Geography (2021-2030)
  • Table 7: Interbody Cages Market in North America (2021-2030)
  • Table 8: Interbody Cages Market in the US (2021-2030)
  • Table 9: Interbody Cages Market in Canada (2021-2030)
  • Table 10: Interbody Cages Market in Mexico (2021-2030)
  • Table 11: Interbody Cages Market in Europe (2021-2030)
  • Table 12: Interbody Cages Market in France (2021-2030)
  • Table 13: Interbody Cages Market in Germany (2021-2030)
  • Table 14: Interbody Cages Market in the United Kingdom (2021-2030)
  • Table 15: Interbody Cages Market in Italy (2021-2030)
  • Table 16: Interbody Cages Market in Spain (2021-2030)
  • Table 17: Interbody Cages Market in the Rest of Europe (2021-2030)
  • Table 18: Interbody Cages Market in Asia-Pacific (2021-2030)
  • Table 19: Interbody Cages Market in China (2021-2030)
  • Table 20: Interbody Cages Market in Japan (2021-2030)
  • Table 21: Interbody Cages Market in India (2021-2030)
  • Table 22: Interbody Cages Market in Australia (2021-2030)
  • Table 23: Interbody Cages Market in South Korea (2021-2030)
  • Table 24: Interbody Cages Market in the Rest of Asia-Pacific (2021-2030)
  • Table 25: Interbody Cages Market in the Middle East (2021-2030)
  • Table 26: Interbody Cages Market in Africa (2021-2030)
  • Table 27: Interbody Cages Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Interbody Cages Market in Global (2021-2030)
  • Figure 3: Interbody Cages Market in Global by Product (2021-2030)
  • Figure 4: Interbody Cages Market in Global by Material (2021-2030)
  • Figure 5: Interbody Cages Market in Global by End-User (2021-2030)
  • Figure 6: Interbody Cages Market in Global by Geography (2021-2030)
  • Figure 7: Interbody Cages Market in North America (2021-2030)
  • Figure 8: Interbody Cages Market in the US (2021-2030)
  • Figure 9: Interbody Cages Market in Canada (2021-2030)
  • Figure 10: Interbody Cages Market in Mexico (2021-2030)
  • Figure 11: Interbody Cages Market in Europe (2021-2030)
  • Figure 12: Interbody Cages Market in France (2021-2030)
  • Figure 13: Interbody Cages Market in Germany (2021-2030)
  • Figure 14: Interbody Cages Market in the United Kingdom (2021-2030)
  • Figure 15: Interbody Cages Market in Italy (2021-2030)
  • Figure 16: Interbody Cages Market in Spain (2021-2030)
  • Figure 17: Interbody Cages Market in the Rest of Europe (2021-2030)
  • Figure 18: Interbody Cages Market in Asia-Pacific (2021-2030)
  • Figure 19: Interbody Cages Market in China (2021-2030)
  • Figure 20: Interbody Cages Market in Japan (2021-2030)
  • Figure 21: Interbody Cages Market in India (2021-2030)
  • Figure 22: Interbody Cages Market in Australia (2021-2030)
  • Figure 23: Interbody Cages Market in South Korea (2021-2030)
  • Figure 24: Interbody Cages Market in the Rest of Asia-Pacific (2021-2030)
  • Figure 25: Interbody Cages Market in the Middle East (2021-2030)
  • Figure 26: Interbody Cages Market in Africa (2021-2030)
  • Figure 27: Interbody Cages Market in South America (2021-2030)
  • Figure 28: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0080

Interbody Cages Market By Product Type (Cervical Fusion Device, Thoracic Fusion Device, And Lumbar Fusion Device), Material (Titanium, Poly-Ether-Ether-Ketone, And Others), End-User (Hospitals, Ambulatory Surgical Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing figure of spinal injuries and the rising geriatric population prone to spinal disorders across the globe

The global interbody cages market is estimated to grow at a CAGR of 4.72% during the forecast period from 2024 to 2030. The demand for interbody cages is primarily being boosted by the increasing number of spinal disorders such as degenerative disc degeneration (DDD), spinal fusion, spinal injuries, and others. Further, the rising adoption of advanced and innovative technologies, the increasing demand for minimally invasive surgeries, the rising cases of accidents, and the increasing product launches & approval among others are thereby contributing to the overall growth of the interbody cages market during the forecast period from 2024-2030.

Interbody Cages Market Dynamics:

The interbody cages market is witnessing a positive growth in product demand owing to various factors, one of the key factors is the increase in the figures of the geriatric population which are prone to spinal and orthopedic disorders.

According to the Government of India, Ministry of Statistics and Programme Implementation 2021, there were nearly 138 million elderly persons in India, 2021 comprising 67 million males and 71 million females.

According to World Health Organization (WHO) 2022, the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. By 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion in 2030. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). In 2050, 80% of older people will be living in low- and middle-income countries. From the same source, in Japan 30% of the population is already over 60 years old.

The intervertebral discs in the spine naturally undergo degenerative changes with age. The discs lose hydration, become less flexible, and may experience wear and tear. These age-related degenerative changes can lead to disc herniation or collapse, requiring surgical intervention, which may need a fusion of the spinal cord. This fusion can be done by using interbody cages, which support the part of the spinal column. Thus, the demand for interbody cages is expected to grow in parallel with the aging population as elderly persons are more prone to spinal and orthopedic diseases.

Also, according to the Centers for Disease and Prevention Control (CDC) May 2022, in the US, each year, 36 million falls occur among older adults aged 65 and >65. One out of five falls causes a serious injury such as broken bones or a head injury.

Coupled with the factors mentioned above, strategic activities such as product launches & approvals, increasing research activities, and others will also contribute to the growth of the interbody cages market during the forecast period from 2024-2030. For instance, in January 2023, FDA approved the Eminent Spine 3D Cervical Interbody Fusion System by Eminent Spine. This system is indicated for intervertebral body fusion in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine at one disc level from the C2-C3 disc to the C7-T1 disc. Thus, the rising product launches and approval and the rising awareness among surgeons, healthcare professionals, and patients about the benefits of interbody cages will increase the demand for interbody cages during the forecast period.

Therefore, the aforementioned factors will propel the overall market growth of interbody cages during the forecast period from 2024-2030.

However, the availability of less skilled professionals, implant-related complications such as misplacement or migration of interbody cages, and others may restrict the interbody cages' market demand.

Interbody Cages Market Segment Analysis:

Interbody cages Market by Product Type (Cervical Fusion Device, Thoracic Fusion Device, and Lumbar Fusion Device), Material (Titanium, Poly-Ether-Ether-Ketone, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the interbody cages, the lumbar fusion device category is expected to amass significant revenue share in the year 2023.

The growth expectations for different product types in the interbody cages market may vary based on various factors, including market trends, advancements in surgical techniques, and the prevalence of specific spinal conditions.

However, in recent years, the lumbar fusion device segment has generally been projected to exhibit significant growth because of the higher prevalence of lumbar spinal disorders such as degenerative disc disease (DDD), spondylolisthesis, and spinal stenosis, which are among the most common conditions affecting the lower back. These conditions often require surgical intervention, including lumbar fusion procedures. The high prevalence of lumbar spinal disorders drives the demand for lumbar fusion devices.

The increasing product launches and approvals will also create a positive impact on the demand for interbody cages which are specifically designed for lumbar spinal fusion during the forecast period from 2024-2030. For instance, in March 2020, FDA approved CarboClear Lumbar Cage System by CarboFix Orthopedics Ltd. This System is indicated for intervertebral body fusion of the lumbar spine in skeletally mature patients with degenerative disc disease (DDD). Thus, the increasing cases of product launches and approval among others may also increase the demand for lumbar fusion devices.

Therefore, the above-mentioned factor, product launches, and approvals are predicted to the increasing demand for this segment type. Hence, driving the growth of the interbody cages market during the forecast period.

North America is expected to dominate the overall Interbody Cages Market:

Among all the regions, North America is estimated to account for the largest share of the interbody cages market in the year 2023. Owing to the significance of key growth factors such as spinal cord injury due to accidents, sports, falls, violence, rising spinal disorders, and others are driving the North American interbody cages market and are expected to witness positive growth during the forecast period. Furthermore, the increasing product launches and approval, the increasing geriatric population in the region, the high disposable income, the sophisticated healthcare infrastructure, the rising regulatory approval for new products, and others will also help the market growth in this region.

According to Spinal Cord Association 2022, most spinal cord injuries happen as a result of a vehicle accident, followed closely by falls, trailed by violence, sports, and medical surgery.

According to the National Spinal Cord Injury Statistical Center 2020, the US population size of 329 million people, a recent estimate showed that the annual incidence of spinal cord injury (SCI) is approximately 54 cases per one million people in the US, or about 17,810 new SCI cases each year. New SCI cases do not include those who die at the location of the incident that caused the SCI. Therefore, these increasing cases of spinal cord injury will need spinal fusion. Subsequently, the interbody cages needed to add extra support and strength to the fusion of the spinal cord, during the surgery. Hence, the increasing number of cases of spinal cord injury in North America will also increase the demand for interbody cages.

The rising product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in August 2021, Alphatec Spine, Inc., a US-based company received FDA approval for PSX Interbody System. The PSX interbody system is indicated for spinal fusion procedures in skeletally mature patients at one or two contiguous levels in the lumbosacral spine (L1-L2 to L5-S1) for the treatment of degenerative disc disease (DDD). DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. Many such developments are taking place that includes product launches and approvals, and collaborations, that can boost the demand for interbody cages in North America. Thus, driving the North American interbody cages market forward during the forecast period.

Thus, the aforementioned factors would provide a growth environment for the North American region in the interbody cages market.

Interbody Cages Market Key Players:

Some of the key market players operating in the interbody cages market include B. Braun SE, Ackermann Instrumente GmbH, Alphatec Spine Inc., Eminent Spine, Medtronics, ZenerMed.com, Rivarp Medical Private Limited, CarboFix Orthopedics Ltd, Intelivation LLC, Medacta International, Surgalign Spine Technologies, SeaSpine Orthopedics Corporation, Elite surgical, Aurora Spine, Inc., Zimmer Biomet, Globus Medical, Johnson & Johnson, Stryker, Ulrich Medical USA, Orthofix US LLC, and others.

Recent Developmental Activities in the Interbody Cages Market:

In April 2021, Alphatec Spine, Inc. received FDA approval for IdentiTiTm ALIF Standalone Interbody System. The IdentiTi ALIF Standalone Interbody System is intended for use at one or two contiguous levels in the lumbar spine (L2-S1) for the treatment of DDD.

In December 2020, FDA approved WaveForm(TM) L Interbody System, WaveForm(TM) TO Interbody System, and WaveForm(TM) TA Interbody System by SeaSpine Orthopedics Corporation. The implants are manufactured from titanium alloy. SeaSpine WaveForm(TM) L System is indicated for use as an adjunct to fusion in skeletally mature patients with degenerative disc disease, defined as back pain of discogenic origin, with degeneration of the disc.

Key Takeaways from the Interbody Cages Market Report Study

Market size analysis for current interbody cages market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global interbody cages market.

Various opportunities are available for the other competitor in the interbody cages market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current interbody cages market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for interbody cages market growth in the coming future?

Target Audience who can be benefited from this Interbody Cages Market Report Study

Interbody cages products providers

Research organizations and consulting companies

Interbody cages-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in interbody cages

Various End-users who want to know more about the interbody cages market and the latest technological developments in the interbody cages market.

Frequently Asked Questions for the Interbody Cages Market:

1. What are interbody cages?

Interbody cages are cylindrical or crescent-shaped, hollow, and porous metallic devices that are placed between two adjacent vertebrae in a spinal segment after removing the damaged disc.

2. What is the market for global interbody cages?

The global interbody cages market is estimated to grow at a CAGR of 4.72% during the forecast period from 2024 to 2030.

3. What are the drivers for the global interbody cages market?

The demand for interbody cages is primarily being heightened by the increasing figure of spinal disorders such as DDD, spinal fractures, spinal deformities, and others. In addition, the rising adoption of advanced and innovative technologies, the increasing product launches & approval, and the rising cases of accidents among others are thereby contributing to the overall growth of the interbody cages market during the forecast period from 2024-2030.

4. Who are the key players operating in the global interbody cages market?

Some of the key market players operating in the interbody cages market include B. Braun SE, Ackermann Instrumente GmbH, Alphatec Spine Inc., Eminent Spine, Medtronics, ZenerMed.com, Rivarp Medical Private Limited, CarboFix Orthopedics Ltd, Intelivation LLC, Medacta International, Surgalign Spine Technologies, SeaSpine Orthopedics Corporation, Elite surgical, Aurora Spine, Inc., Zimmer Biomet, Globus Medical, Johnson & Johnson, Stryker, Ulrich Medical USA, Orthofix US LLC, and others.

5. Which region has the highest share in the interbody cages market?

North America is expected to dominate the overall interbody cages market during the forecast period from 2024-2030. Owing to the factors such as the rising prevalence of spinal disorders, the rising geriatric population in the region, and other factors will increase the North American interbody cages market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and others will also help the market growth in this region.

Table of Contents

1.Interbody Cages Market Report Introduction

2. Interbody Cages Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Interbody Cages Market Key Factors Analysis

  • 4.1. Interbody Cages Market Drivers
    • 4.1.1. Rising prevalence of the spinal disorders
    • 4.1.2. Increasing patient demand for pain relief and improved quality of life using different treatment approaches
    • 4.1.3. Increasing geriatric population prone to spinal and orthopedic disorders
  • 4.2. Interbody Cages Market Restraints and Challenges
    • 4.2.1. Implant-related complications such as misplacement or migration of interbody cage
    • 4.2.2. Availability of less skilled professionals
  • 4.3. Interbody Cages Market Opportunities
    • 4.3.1. Increasing technological advancements such as biodegradable interbody cages, and 3D-printed cages, among others
    • 4.3.2. The adoption of a robotic-assisted interbody cage placement procedure

5. Interbody Cages Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. The threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Interbody Cages Market Layout

  • 6.1. By Product Type
    • 6.1.1. Cervical Fusion Device
    • 6.1.2. Thoracic Fusion Device
    • 6.1.3. Lumbar Fusion Device
  • 6.2. By Material
    • 6.2.1. Titanium
    • 6.2.2. Poly-Ether-Ether-Ketone (PEEK)
    • 6.2.3. Others
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North American Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.1.1. United States Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Interbody Cages Market Size in USD million (2021-2030)
    • 6.4.2. Europe Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.2.1. France Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Interbody Cages Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.3.1. China Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.3.3. India Interbody Cages Market Size in USD MILLION (2021-2030)
      • 6.4.3.4. Australia Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of the Asia-Pacific Interbody Cages Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.4.1. Middle East Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Interbody Cages Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Interbody Cages Market Size in USD million (2021-2030)

7. Interbody Cages Market Company and Product Profiles

  • 7.1. B. Braun SE
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Ackermann Instrumente GmbH
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Alphatec Spine Inc.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Eminent Spine
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Medtronic plc
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Zener Medtec
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Rivarp Medical Private Limited
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. CarboFix Orthopedics Ltd
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Intelivation LLC
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Medacta International
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Surgalign Spine Technologies
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. SeaSpine Orthopedics Corporation
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Elite Surgical
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Aurora Spine, Inc.
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Zimmer Biomet
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. Globus Medical
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. Johnson & Johnson
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy
  • 7.18. Stryker
    • 7.18.1. Company Overview
    • 7.18.2. Company Snapshot
    • 7.18.3. Financial Overview
    • 7.18.4. Product Listing
    • 7.18.5. Entropy
  • 7.19. Ulrich Medical USA
    • 7.19.1. Company Overview
    • 7.19.2. Company Snapshot
    • 7.19.3. Financial Overview
    • 7.19.4. Product Listing
    • 7.19.5. Entropy
  • 7.20. Orthofix US LLC
    • 7.20.1. Company Overview
    • 7.20.2. Company Snapshot
    • 7.20.3. Financial Overview
    • 7.20.4. Product Listing
    • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us